Skip to content

DBV Technologies DBVT Total Liabilities & Equity

Total Liabilities & Equity at other companies

Avalo Therapeutics logo
Avalo TherapeuticsAVTX
$99.89M-27.9%
Cullinan Therapeutics, Inc. logo
Cullinan Therapeutics, Inc.CGEM
$402.98M-30.5%
Celldex Therapeutics logo
Celldex TherapeuticsCLDX
$511.25M-30.9%
Nektar Therapeutics logo
Nektar TherapeuticsNKTR
$763.27M+198%
Kymera Therapeutics logo
Kymera TherapeuticsKYMR
$1.67B+81.7%
Alumis Inc. logo
Alumis Inc.ALMS
$671.59M+157%

Other financials

Income statement

See full
Revenue$900.0K+12.5%
Operating income-$47.9M-80.1%
Net income-$47.6M-75.6%
EPS (diluted)-$0.11+57.7%

Balance sheet

See full
Cash & equivalents$229.2M+1,668%
Total debt$6.1M-15.7%
Total equity$207.9M+7,069%
Total assets$266.4M+427%

Cash flow

See full
Operating cash flow-$49.1M-149%
CapEx$400.0K
Free cash flow-$49.5M-151%

Valuation

See full
Market cap$948.17M+269%
Enterprise value$725.07M+188%
P/S163.9×+91.4×

Profitability

See full
Operating margin-2,910.4%-265pp
Net margin-2,895.4%-257pp
FCF margin-2,619.5%+69.9pp

Returns & leverage

See full
Return on equity-158.9%-26.4pp
Debt / equity-2.5×
Current ratio4.8×+4.0×

Where this comes from

Reported directly by DBV Technologies in its filing.

Tagged under the XBRL concept us-gaap:LiabilitiesAndStockholdersEquity.

The official record: DBV Technologies’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about DBV Technologies's total liabilities & equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is DBV Technologies's total liabilities & equity?
DBV Technologies (DBVT) reported total liabilities & equity of $266.4M in Q1 2026.
How has DBV Technologies's total liabilities & equity changed year-over-year?
DBV Technologies's total liabilities & equity increased by 426.9% year-over-year, from $50.56M to $266.4M.
What is the long-term trend for DBV Technologies's total liabilities & equity?
Over 5 years (2020 to 2025), DBV Technologies's total liabilities & equity has grown at a -3.0% compound annual growth rate (CAGR), from $272.25M to $233.7M.
What does total liabilities & equity mean?
Total assets = total liabilities + total equity. This must always balance — a fundamental accounting identity.